Andrey L. Komarov

Andrey L. Komarov

Auto-generated profile, based on publicly available information

Andrey L. Komarov

National Medical Research Centre of Cardiology Named after Academician E.I. Chazov

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2002 in European Heart Journal
Verified
Journal Article
Open access
PDF file
AKA.L. Komarov
A.L. Komarov
EPE.P. Panchenko
E.P. Panchenko
ADA.B. Dobrovolsky
A.B. Dobrovolsky
YKYu.A. Karpov
Yu.A. Karpov
ADA.D. Deev
A.D. Deev
AEA.R. Eshkeeva
A.R. Eshkeeva
Aims To evaluate the frequency of arterial thrombotic events in patients with peripheral arterial occlusive disease during 3–5 years of follow-up and

30 March 2021 in Eurasian heart journal
Verified
Journal Article
Open access
PDF file
EPElizaveta Panchenko
Elizaveta Panchenko
TBTatyana Balakhonova
Tatyana Balakhonova
NDN. M. Danilov
N. M. Danilov
AKA. L. Komarov
A. L. Komarov
EKE. S. Kropachyova
E. S. Kropachyova
IYI. S. Yavelov
I. S. Yavelov
Disclaimer.The EAC Guidelines represent the views of the EAC, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The EAC is not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the EAC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the EAC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the EAC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient’s health condition and in consultation with that patient and, where appropriate and/or necessary, the patient’s caregiver. Nor do the EAC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient’s case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional’s responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.

28 February 2021 in Kardiologiia
Verified
Journal Article
Open access
PDF file
SBSergey Boytsov
Sergey Boytsov
NPN. V. Pogosova
N. V. Pogosova
FPF. N. Paleev
F. N. Paleev
MEM. V. Ezhov
M. V. Ezhov
AKA. L. Komarov
A. L. Komarov
OMO. V. Milko
O. V. Milko
Aim      To evaluate the clinical picture and factors associated with unfavorable outcomes in admitted patients with COVID-19. Material and methods This study included all patients admitted to the COVID Center of the National Research Center of Cardiology of the Russian Ministry of Health Care from May 1 through May 31, 2020. Clinical demographic, laboratory, and instrumental indexes and associated factors were studied with one-way and multivariate logistic regression analysis. Results This study included 402 patients aged 18 to 95 years (mean age, 62.9±14.6 years); 43.0 % of them were older than 65 years. COVID-19 was frequently associated with chronic comorbidities, including arterial hypertension (74.4 %), obesity (41.6 %), history of ischemic heart disease (12.9 %), atrial fibrillation (18.9 %), type 2 diabetes mellitus (DM) (13.0 %), and oncological diseases (9.2 %). 13.0 % of patients were smokers; less than 10% had chronic lung diseases. 3.9% of patients had a combination of COVID-19 and acute coronary pathology, including acute myocardial infarction (MI) in 3.2 % (13) and unstable angina in 0.7 % (3). The most frequent clinical manifestation of COVID-19 were four symptoms: cough (81.1 %), weakness (80.3 %), shortness of breath (71.6 %), and fever (62.7 %). 46.5% of patients had shortage of breath and chest pain/compression, 40.3% had headache, 31.1% had myalgia, 28.8% had anosmia, and 25.5% had ageusia. Arterial oxygen saturation was 55 years, NEWS scale score >4.0, oxygen saturation 5.4 mmol/l, hs-CRP >25.7 mg/l, and creatinine clearance <72.0 ml/min. Furthermore, the risk increased with increasing degree of changes in each factor. According to results of the multivariate regression analysis, three most significant predictors of the hard endpoint, all-cause death during the stay in the hospital, were more than 5-fold increases in aspartate aminotransferase and/or alanine aminotransferase compared to normal levels (relative risk (RR) 16.8 at 95 % confidence interval (CI) 5.0–56.3, р<0.001), pronounced changes in the lungs consistent with a CT-4 picture as shown by computed tomography (CT) (RR 13.4; 95 % CI 3.9–45.5, р<0.001), and MI/unstable angina during the stay in the hospital (RR 11.3; 95 % CI 1.4–90.6, р=0.023). The probability of death was also considerably increased by chronic obstructive pulmonary disease, impaired kidney function (creatinine clearance estimated by Cockcroft-Gault <60.0 ml/min), type 2 DM, oncological diseases, and dementia. Conclusion      This study established factors associated with unfavorable outcomes in admitted patients with COVID-19. This will allow identifying in advance patients with a high risk of complications that require increased attention to take more active diagnostic and therapeutic measures at prehospital and hospital stages.

26 May 2021 in Eurasian heart journal
Verified
Journal Article
Open access
PDF file
ICI. E. Chazova
I. E. Chazova
MSMarina Shestakova
Marina Shestakova
YZYu. V. Zhernakova
Yu. V. Zhernakova
NBN. V. Blinova
N. V. Blinova
TMT. N. Markova
T. N. Markova
ANA. R. Narzullaeva
A. R. Narzullaeva
ЕВРАЗИЙСКИЕ РЕКОМЕНДАЦИИ ПО ПРОФИЛАКТИКЕ И ЛЕЧЕНИЮ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ У БОЛЬНЫХ С ДИАБЕТОМ И ПРЕДИАБЕТОМ (2021)

25 November 2021 in Eurasian heart journal
Verified
Journal Article
Open access
PDF file
OBOlga Barbarash
Olga Barbarash
AKA. L. Komarov
A. L. Komarov
EPElizaveta Panchenko
Elizaveta Panchenko
ISI. I. Staroverov
I. I. Staroverov
RSR. M. Shahnovich
R. M. Shahnovich
IYI. S. Yavelov
I. S. Yavelov
The EAC Guidelines represent the views of the EAC, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The EAC is not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the EAC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the EAC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the EAC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient’s health condition and in consultation with that patient and, where appropriate and/or necessary, the patient’s caregiver. Nor do the EAC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient’s case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional’s responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.

14 May 2021 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
OTO. N. Tkacheva
O. N. Tkacheva
NVNatalya Vorobyeva
Natalya Vorobyeva
YKYu. V. Kotovskaya
Yu. V. Kotovskaya
NRN. K. Runikhina
N. K. Runikhina
ISI. D. Strazhesco
I. D. Strazhesco
IYI. S. Yavelov
I. S. Yavelov
В данном документе обсуждаются особенности АТТ у лиц пожилого и старческого возраста в различных клинических ситуациях.